Global Point of Care Diagnostics Market to Grow with a CAGR of 7.2% from 2022-2027

The Point of Care Diagnostics Market is expected to be USD 44 Billion by 2027. Point-of-care testing is essential for rapidly detecting analyses near the patient, facilitating better monitoring, disease diagnosis, and management. POC tests are executed outside central laboratories and produce quick results. POC has been a vital goal in vitro diagnostics, and new consequences have made achieving it possible. Point of care diagnostics will be part of a paradigm shift from corrective medicine to predictive, personalized, and preemptive treatment.